What to know about variable heart rhythms and AFib
An Ohio State cardiac electrophysiologist shares what to know about heart rhythms and AFib.
The Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences provides national and international recognition and support to those at the forefront of cardiovascular sciences.
The recipient will be a leader in cardiovascular sciences, a physician or biomedical scientist who has made extraordinary and sustained leadership contributions to improving health care.
The Schottenstein Laureate will also receive an honorarium of $100,000 (US).
Established by a $2 million endowment from humanitarian philanthropists Jay and Jeanie Schottenstein, the prize is chartered to The Ohio State University Wexner Medical Center’s Heart and Vascular Center, and will be awarded biennially.
The nomination period for the 2019 Prize has closed.
View photos from the 2017 Schottenstein Prize ceremony here.
A native of Montreal, Canada, Dr. Roden received his medical degree and trained in Internal Medicine at McGill University. He began his career at Vanderbilt University School of Medicine where he remains today, servings as Professor of Medicine, Pharmacology and Biomedical Informatics and as Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center. His research program studies how genetic variation affects human disease susceptibility, with a focus in cardiac rhythm abnormalities, and responses to drugs, also known as pharmocogenetics. After serving as chief of the division of Clinical Pharmacology for 12 years, he was tasked in 2006 with leading Vanderbilt’s efforts in Personalized Medicine. Under his leadership, Vanderbilt has become internationally-recognized for cutting edge programs in this area, including the large (250,000 sample) biobank BioVU and the EHR-based preemptive pharmacogenetic program PREDICT. He has been Principal Investigator for the Vanderbilt sites of the Pharmacogenomics Research Network since 2001 and of the Electronic Medical Records and Genomics (eMERGE) Network since 2007.
Dr. Garret FitzGerald is the McNeil Professor in Translational Medicine and Therapeutics at the University of Pennsylvania in Philadelphia, where he chairs the Department of Pharmacology and directs the Institute for Translational Medicine and Therapeutics.
Christine Seidman, MD is Professor, Departments of Medicine and Genetics at Harvard Medical School and Brigham and Women’s Hospital, where she is also the Thomas W. Smith Professor of Medicine.
Pascal Goldschmidt, MD, was the inaugural recipient of the Schottenstein Prize. He is the Senior Vice President for Medical Affairs and Dean at the University of Miami Miller School of Medicine, and also serves as Chief Executive Officer of the University of Miami Health System.
Dr. Roberto Bolli leads the Division of Cardiovascular Medicine, directs the Institute of Molecular Cardiology and serves as the scientific director of the Cardiovascular Innovation Institute at the University of Louisville. He also serves as the executive vice chair of the Department of Medicine.
This prestigious prize provides national and international recognition to a physician or biomedical scientist who has made extraordinary and sustained leadership contributions to improving health care or who has successfully pursued innovative biomedical research with demonstrated translational benefits to patient care.
Those honored will be practitioners and/or scientists whose accomplishments and contributions have taken place over a career of dedicated and focused scientific discovery.
The prize is awarded biennially.
We are now accepting nominations for the 2019 Schottenstein Prize. Nominations are being accepted through January 31, 2019. Please click here to access the nomination form and requirements.
Jay and Jeanie Schottenstein are passionate about Ohio State. Their children – Joseph, Jeffrey and Jonathan – each have attended, or are attending The Ohio State University. Jeanie herself is a graduate.
The passion doesn’t stop there. Jay and Jeanie and Jay’s parents and siblings all have philanthropic ties to the university; the Jerome Schottenstein Center bears his late father's name. One might say the colors of scarlet and gray run deep in Jay’s and Jeanie’s veins.
It was natural, then, for them to pledge $2 million to The Ohio State University Wexner Medical Center in 2008 to create the Jay and Jeanie Schottenstein Prize in Cardiovascular Science. The prize establishes an endowed fund to award up to $100,000 biennially to a physician or researcher who is an international leader in the field of cardiovascular sciences.
Because prizes of such magnitude are rare in scientific research and medicine, the Schottenstein Prize was expected to generate a lot of excitement.
"By providing this prize for cardiovascular sciences, we hope to further establish Ohio State as a leader in cardiovascular care and assure that it continues to set the bar for other institutions, nationally and internationally,” Jay said.
“This award will create a connection between Ohio State and some of the most outstanding cardiovascular scientists in the world,” added Jeanie. “Our goal in establishing this prize is to make a strong institution even stronger.”
According to Ohio State’s Heart and Vascular Center Director, Thomas Ryan, MD, this prize not only provides international recognition to someone who is on the leading edge of his or her field, but it will also offer an unparalleled educational opportunity for Ohio State’s academic, medical and research communities and the community at large. The awarding of this prize will expose these groups to the knowledge and discoveries of a physician or researcher of great talent and caliber.
“Our vision at Ohio State’s Heart and Vascular Center is to leverage advanced techniques and technologies to innovate and translate knowledge into personalized heart care,” explains Ryan. “The Schottenstein Prize offers another avenue through which to accomplish this.”
“The creation of the Schottenstein Prize addresses two important goals. First, it greatly enhances the reputation of OSU on the international stage as an institution where world-class science is recognized and valued. Second, it will expose our students, trainees, and faculty to the luminaries in modern cardiovascular medicine. I am both grateful and proud that we have been afforded this wonderful opportunity.”
Get tips from Ohio State experts right to your inbox.